Parent Interventions: Navigating through the Pandemic  |  Health Monitor: Attention and Memory Deficits in People Who Experienced Mild Covid  |  Parent Interventions: How can we Revert Peanut Allergies in Children?  |  Teacher Insights: Play Based Learning has a Positive Impact on Child's Learning and Development  |  Health Monitor: Social Media Use Likely to Affect the Physical Health of a Person  |  Parent Interventions: How to Deal with Developmental Language Disorder in Children  |  Health Monitor: Lifestyle Interventions from Early Childhood Prevents Cardiovascular Diseases  |  Teacher Insights: Teacher Expectations Can Have Powerful Impact on Students Academic Achievement  |  Policy Indications: Make Sure the Digital Technology Works for Public Good  |  Teacher Insights: The Significance of Social Emotional Learning Curriculum in Schools  |  Health Monitor: Forgetting is a Form of Learning  |  Higher Studies: University of Manchester Invites Application for LLB and LLM Programmes   |  Health Monitor: Is There a Blue Spot Inside our Brain?  |  Parent Interventions: Babies born during the Pandemic Performs Lower during Developmental Screening  |  Policy Indications: Invest in Structural Steel R&D : Prof BS Murty  |  
May 07, 2020 Thursday 10:50:21 PM IST

Scientists to culture novel coronavirus in human lung epithelial cell

Science Innovations

Centre for Cellular and Molecular Biology (CCMB), Hyderabad has tied up with a Bengaluru-based company, Eyestem Research Private Limited, to take up research activities on COVID-19. Through this research collaboration, an attempt will be made to grow novel coronavirus in human cell lines, which will enable in vitro testing of potential drugs and vaccines against the COVID-19. The research team will use Eyestem's human lung epithelial cell culture system provided as part of its Anti-COVID Screening (ACS) platform to understand the molecular and pathological characteristics of the novel coronavirus, with a view of establishing a rational basis for testing potential drugs in vitro, said CCMB scientists.

CCMB is a constituent laboratory of the Council of Scientific and Industrial Research (CSIR) known for its cutting-edge research work on cellular and molecular biology. Eyestem Research Private Limited is a cell therapy start-up incubated at the Centre for Cellular and Molecular Platforms (C-CAMP), Bengaluru. C-CAMP is an initiative of the Department of Biotechnology, Ministry of Science and Technology.

Dr. Jogin Desai, CEO, Eyestem, expressed hope that CCMB will be able to leverage its platform and advance COVID-19 research that will help the country. “The ACS platform has been developed by Dr. Rajarshi Pal and his team and is a testament to our depth and expertise in cell therapy and disease modeling,” he said.

Eyestemis working to democratize access to cell therapy as well as disease modeling platforms and bring their benefit to a large section of humanity, added Dr. Desai.



Comments